Absorption and distribution of naproxen in rats orally treated with naproxen betainate sodium salt monohydrate. Comparison with naproxen

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 4, 1997, Pages 381-384

  Marzo, Antonio ^a,c   Ripamonti, Marco ^a   Benatti, Paola ^a   Marzo, Paolo ^a   Wool, Corinne ^b   Cerutti, Renata ^b   Reiner, Valentina ^a  

^a Lab of Pharmacokin and Drug Metab   (Italy)

^b Bracco SpA   (Italy)

^c Department of Clinical Pharmacology ^*  (Switzerland)

Author keywords

anti inflammatory drugs, non steroidal; Aprenin ; CAS 104124 26 7; CAS 22204 53 1; CAS 26159 34 2; naproxen; naproxen betaNa, bioavailability, naproxen plasma concentrations, tissue distribution; S naproxen; S naproxen betainate sodium salt monohydrate

Indexed keywords

APRENIN; NAPROXEN; NAPROXEN BETAINATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ENANTIOMER; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; LUNG; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STOMACH MUCOSA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INTESTINAL ABSORPTION; MALE; NAPROXEN; RATS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION;

EID: 0030988173     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Harrison, I. T., Lewis, B., Nelson, P. et al., J. Med. Chem. 13, 203 (1970)
2. Adams, S. S., Bresloff, P., Mason, C. G., J. Pharm. Pharmacol. 28, 256 (1976)
3. Smith, R. L., Caldwell, J., Trends Pharmacol. Sci. 9, 75 (1988)
4. Caldwell, J. C., Winter, S. M., Hutt, A. J., Xenobiotica 18, 59 (1988)
5. Ariens, E. J., Eur. J. Clin. Pharmacol. 26, 663 (1984)
6. CPMP working party on quality of medicinal products; CPMP working party on safety of medicinal product; CPMP working party on efficacy of medicinal products; Note for guidance: Investigation of chiral active substances, III/3601/91 - EN - final, October 1993; Rules Governing Medicinal Products in the EC, Vol. III, Add. 3 (1995)
7. Marzo, A., Arzneim.-Forsch./Drug Res. 44 (I), 791 (1994)
8. Campbell, D. B., Eur. J. Drug Metab. Pharmacokinet. 15, 109 (1990)
9. Runkel, R., Forchielli, E., Boost, G. et al., Scand. J. Rheumatol. 2 (Suppl.), 29 (1973)
10. Lee, E. J. D., Williams, K., Day, R. et al., Br. J. Clin. Pharmacol. 19, 669 (1985)
11. Sevelius, H., Runkel, R., Segre, E. et al., Br. J. Clin. Pharmacol. 10, 259 (1980)